Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank71
5Y CAGR-20.7%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-20.7%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 8.07% |
| 2023 | -2.50% |
| 2022 | -15.83% |
| 2021 | -239.60% |
| 2020 | 88.55% |
| 2019 | 25.67% |
| 2018 | -76.56% |
| 2017 | -84.36% |
| 2016 | -51.45% |
| 2015 | -66.82% |